Ignite Creation Date:
2024-05-06 @ 8:36 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02773849
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2016-04-19
Brief Title:
ADSTILADRIN INSTILADRIN in Patients With High-Grade Bacillus Calmette-Guerin BCG Unresponsive Non-Muscle Invasive Bladder Cancer NMIBC
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-19
First Submit QC Date:
May 12 2016
Study First Post Date:
2016-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-07-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-05-11
Disp First Submit QC Date:
May 11 2020
Disp First Post Date:
2020-05-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-07-26
Last Update Post Date:
2023-12-22
Last Update Post Date Type:
ACTUAL